• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

作者信息

Hoekstra Pieter J, Buitelaar Jan K

机构信息

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, and Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands.

出版信息

Eur Child Adolesc Psychiatry. 2016 Apr;25(4):339-40. doi: 10.1007/s00787-016-0845-2.

DOI:10.1007/s00787-016-0845-2
PMID:27021055
Abstract
摘要

相似文献

1
Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?哌甲酯用于治疗儿童和青少年注意力缺陷/多动障碍的证据基础是否存在缺陷？
Eur Child Adolesc Psychiatry. 2016 Apr;25(4):339-40. doi: 10.1007/s00787-016-0845-2.
2
Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.用于注意力缺陷/多动障碍的哌甲酯：最长的争论。
Aust N Z J Psychiatry. 2016 Jul;50(7):616-7. doi: 10.1177/0004867416643390. Epub 2016 Apr 11.
3
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.对于患有注意缺陷多动障碍的儿童和青少年，哌醋甲酯的益处和危害仍存在争议。
Clin Pharmacol Ther. 2018 Oct;104(4):606-609. doi: 10.1002/cpt.1149. Epub 2018 Jul 13.
4
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.盐酸哌甲酯控释片治疗韩国注意缺陷多动障碍儿童的疗效与耐受性评价
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. doi: 10.1016/j.pnpbp.2007.03.018. Epub 2007 Apr 1.
5
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.文拉法辛与哌甲酯治疗儿童注意缺陷多动障碍门诊患者的随机双盲对照试验
Hum Psychopharmacol. 2010 Nov;25(7-8):530-5. doi: 10.1002/hup.1148. Epub 2010 Sep 22.
6
Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.注意缺陷多动障碍儿童在使用兴奋剂治疗前后的视野情况。
Acta Ophthalmol. 2010 Mar;88(2):e56. doi: 10.1111/j.1755-3768.2009.01520.x. Epub 2009 Jun 5.
7
Methylphenidate (Ritalin) use and abuse.哌甲酯（利他林）的使用与滥用。
S Afr Med J. 1999 Oct;89(10):1076-9.
8
Question 2 Should a child with ADHD and epilepsy be given ritalin?问题2：患有注意力缺陷多动障碍（ADHD）和癫痫的儿童应该服用利他林吗？
Arch Dis Child. 2010 Sep;95(9):759-61. doi: 10.1136/adc.2010.193144.
9
Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.儿童注意力缺陷多动障碍中的哌甲酯透皮系统：劳尔·R·席尔瓦的观点
Drugs. 2006;66(8):1127-8; discussion 1128. doi: 10.2165/00003495-200666080-00008.
10
Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.注意力缺陷/多动障碍及正常儿童对哌甲酯的反应：2002年更新
J Atten Disord. 2002;6 Suppl 1:S57-60. doi: 10.1177/070674370200601s07.

引用本文的文献

1
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍（ADHD）儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
2
Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?哌甲酯对患有注意力缺陷多动障碍的儿童和青少年有效吗？
Pediatr Rep. 2021 Aug 1;13(3):434-443. doi: 10.3390/pediatric13030050.
3
Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.

本文引用的文献

1
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
2
Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.医疗服务提供者诊断并用药治疗的注意力缺陷/多动障碍的家长报告趋势：美国，2003 - 2011年
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2. doi: 10.1016/j.jaac.2013.09.001. Epub 2013 Nov 21.
3
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
西班牙注意缺陷多动障碍的患病率和共病情况：一项扩展系统评价的研究方案，对观察性研究进行更新的荟萃分析。
Syst Rev. 2019 Feb 11;8(1):49. doi: 10.1186/s13643-019-0967-y.
4
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.ADHD 的治疗策略：选择最佳治疗的循证指南。
Mol Psychiatry. 2019 Mar;24(3):390-408. doi: 10.1038/s41380-018-0116-3. Epub 2018 Jun 28.
5
Towards a better understanding of the many facets of attention-deficit/hyperactivity disorder.迈向对注意力缺陷多动障碍多方面的更好理解。
Eur Child Adolesc Psychiatry. 2018 Mar;27(3):261-262. doi: 10.1007/s00787-018-1141-0.
6
Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.与法国 ADHD 儿童推荐使用哌醋甲酯治疗相关的临床因素。
Eur Child Adolesc Psychiatry. 2018 Mar;27(3):367-376. doi: 10.1007/s00787-017-1061-4. Epub 2017 Oct 5.
7
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.考科蓝协作网撤回了一项关于哌甲酯用于成人注意力缺陷多动障碍的综述。
Evid Based Med. 2017 Aug;22(4):143-147. doi: 10.1136/ebmed-2017-110716. Epub 2017 Jul 13.
8
Attention-Deficit/Hyperactivity Disorder.注意缺陷多动障碍。
Dtsch Arztebl Int. 2017 Mar 3;114(9):149-159. doi: 10.3238/arztebl.2017.0149.
9
What do general practitioners know about ADHD? Attitudes and knowledge among first-contact gatekeepers: systematic narrative review.全科医生对注意力缺陷多动障碍了解多少？首诊把关者的态度和知识：系统叙述性综述。
BMC Fam Pract. 2016 Sep 7;17(1):129. doi: 10.1186/s12875-016-0516-x.
10
Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.回应：事实上，哌甲酯用于治疗儿童和青少年注意力缺陷多动障碍的证据基础存在缺陷。
Eur Child Adolesc Psychiatry. 2016 Sep;25(9):1039-40. doi: 10.1007/s00787-016-0856-z.
针对患有自闭症谱系障碍、注意力缺陷多动障碍及其他精神疾病的儿童和青少年，其使用注意力缺陷多动障碍药物的全国患病率增长了五倍：一项基于丹麦登记处的研究。
J Child Adolesc Psychopharmacol. 2013 Sep;23(7):432-9. doi: 10.1089/cap.2012.0111. Epub 2013 Sep 9.
4
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.德国注意缺陷/多动障碍的年龄特异性患病率、新诊断发病率及药物治疗情况。
J Child Adolesc Psychopharmacol. 2012 Aug;22(4):307-14. doi: 10.1089/cap.2011.0064. Epub 2012 Aug 2.